Larry Ramer

Larry Ramer

InvestorPlace Contributor

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

GDEV, HHR, OZON, QIWI, YNDX: Can You Trade Russian Stocks on the Nasdaq?

By Larry Ramer, InvestorPlace Contributor

The Russian stock market partially reopened today, but the trading of a number of Russian stocks remains halted in the U.S.

Why Is Cresco Labs (CRLBF) Stock in the Spotlight Today?

By Larry Ramer, InvestorPlace Contributor

Cresco Labs has agreed to acquire one of its major rivals, Columbia Care, in exchange for CRLBF stock in a roughly $2 billion deal.

Why Is Aurora Cannabis (ACB) Stock Up Today?

By Larry Ramer, InvestorPlace Contributor

ACB stock is climbing after Aurora announced that it would acquire an award-winning Canadian cannabis company called Thrive.

Dear ORPH Stock Fans, Mark Your Calendars for March 31

By Larry Ramer, InvestorPlace Contributor

After Orphazyme announced that it would withdraw the application for approval of its drug and delist its ADSs, ORPH stock is falling.

Why Is Alibaba (BABA) Stock Up Today?

By Larry Ramer, InvestorPlace Contributor

After Alibaba raised the size of its share buybacks, investors appear to believe that the company is increasingly confident in BABA stock.

Load More